Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Meningeal Carcinomatosis 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Chromosome 5q Deletion Syndrome 1

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 3Tacrolimus 3Methotrexate 3Busulfan 3Mycophenolic Acid 2Filgrastim 2Cyclophosphamide 2Antilymphocyte Serum 2merphos 1Whole-Body Irradiation 1Resistance Training 1Pharmacogenomic Testing 1Oxycodone 1Ondansetron 1Mutation 1Music Therapy 1Moxifloxacin 1Morphine 1Methadone 1Massage 1Fluorescent Antibody Technique 1Flow Cytometry 1Endoscopy, Digestive System 1Diet, Mediterranean 1Diagnosis 1Cytogenetic Analysis 1Cyclosporine 1Ciprofloxacin 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Thrombocythemia, Essential × merphos × Clear all
NCT00445744 2018-01-02

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase NA Completed
52 enrolled 7 charts
MyeloidOther hematologic neoplasm

Chromosome 5q Deletion Syndrome, Congenital Abnormalities, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡